Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
My prognosis with stage 4 squamous cell carcinoma of the mandible is 50 percent with surgery plus 7 weeks chemo at 5 days per week and radiation. They want to throw the kitchen sink at me. Cancer Coach-
Continue readingA world-first trial has found patients with a type of skin cancer called squamous cell carcinoma can be spared the effects of chemotherapy and treated using surgery and post-operative radiotherapy. Squamous
Continue reading“However, all current treatment regimens for head and neck cancer have adverse effects. Therefore, continuing investigations have been undertaken to seek less toxic therapies to reduce treatment
Continue readingThe Increased Risk of Melanoma from Sun Lamp Use is Small… So Why Worry? The study of melanoma is complicated. When I talk to my teenage son about risks, any kind of risks, his eyes glaze over.
Continue readingGot Spots (Actinic Keratosis-pre-skin cancer) on Your Bald Head? Get a Closer Look to Distinguish AK vs. IC vs. SCC- Time was when your Primary Care Physician or Dermatologist looked closely at your
Continue readingOn the other hand, preclinical and clinical studies have demonstrated that collagen may slow the development of (pancreatic cancer) cells to some extent under some conditions. Hi David- What about the
Continue readingCurcumin (diferuloylmethane), a derivative of the spice turmeric (Curcuma longa), is nontoxic to humans (<a c
Continue readingEllagic acid was previousely shown to have anticarcinogenic, antioxidant and antifibrosis properties. The anticarcinogenic effect of ellagic acid was shown in several types of cancers including
Continue readingWhen researchers added a curcumin-based compound to head and neck cancer cell lines, they were able to cut the dose of the chemotherapy drug cisplatin by four while still killing tumor cells equally as
Continue readingThe analysis included 24 patients (median age, 60 years; men, n = 20) with incurable HPV-16-related cancers (oropharyngeal, n = 22; cervical, n = 1; anal, n = 1). The good news is that the therapies Nivolomab
Continue readingBackground: The objective of this study is to assess the risk of second primary cancers following a first primary esophageal cancer as well as the risk of esophageal cancer as a second primary, following
Continue reading“PDT provides a surgical oncologic modality for potentially curative treatment of early stage oral cavity and laryngeal malignancies with minimal side effects, absence of systemic toxicity, preservation
Continue reading